[CLINICAL AND METABOLIC STUDY IN PEDIATRICS WITH A NEW ANABOLIC STEROID (4-HYDROXY-19-NORTESTOSTERONE-17-CYCLOPENTYLPROPIONATE)].
D045930:Anabolic Agents; D001996:Bronchopneumonia; D002648:Child; D003677:Deficiency Diseases; D004392:Dwarfism; D004827:Epilepsy; D004899:Erythroblastosis, Fetal; D006330:Heart Defects, Congenital; D007223:Infant; D008607:Intellectual Disability; D007565:Jaundice; D007567:Jaundice, Neonatal; D009069:Movement Disorders; D009277:Nandrolone; D010372:Pediatrics; D013256:Steroids
D045930:Anabolic Agents; D013256:Steroids; D009277:Nandrolone
ANABOLIC STEROIDS; BRONCHOPNEUMONIA; CHILD; DEFICIENCY DISEASES; DWARFISM; EPILEPSY; ERYTHROBLASTOSIS, FETAL; HEART DEFECTS, CONGENITAL; INFANT; JAUNDICE, NEONATAL; MENTAL RETARDATION; MOVEMENT DISORDERS; PEDIATRICS
STUDIO CLINICO E METABOLICO IN PEDIATRIA CON UN NUOVO STEROID ANABOLIZZANTE (4-IDROSSI-19-NORTESTOSTERONE-17-CICLOPENTILPROPIONATO)